Alpha1-adrenoceptors are required for normal male sexual function.

BACKGROUND AND PURPOSE: Alpha(1)-adrenoceptor antagonists are extensively used in the treatment of hypertension and lower urinary tract symptoms associated with benign prostatic hyperplasia. Among the side effects, ejaculatory dysfunction occurs more frequently with drugs that are relatively selective for alpha(1A)-adrenoceptors compared with other drugs of this class. This suggests that alpha(1A)-adrenoceptors may contribute to ejaculation. However, this has not been studied at the molecular level. EXPERIMENTAL APPROACH: The physiological contribution of each alpha(1)-adrenoceptor subtype was characterized using alpha(1)-adrenoceptor subtype-selective knockout (KO) mice (alpha(1A)-, alpha(1B)- and alpha(1D)-AR KO mice) since the subtype-specific drugs available are only moderately selective. We analysed the role of alpha(1)-adrenoceptors in the blood pressure and vascular response as well as ejaculation by determining these variables in alpha(1)-adrenoceptor subtype-selective KO mice and in mice with all their alpha(1)-adrenoceptor subtypes deleted (alpha(1)-AR triple-KO mice). KEY RESULTS: The pregnancy rate was reduced by 50% in alpha(1A)-adrenoceptor KO mice, and this reduction was dramatically enhanced in alpha(1)-adrenoceptor triple-KO mice. Contractile tension of the vas deferens in response to noradrenaline was markedly decreased in alpha(1A)-adrenoceptor KO mice, and this contraction was completely abolished in alpha(1)-adrenoceptor triple-KO mice. This attenuation of contractility was also observed in the electrically stimulated vas deferens. CONCLUSIONS AND IMPLICATIONS: These results demonstrate that alpha(1)-adrenoceptors, particularly alpha(1A)-adrenoceptors, are required for normal contractility of the vas deferens and consequent sperm ejaculation as well as having a function in fertility.

Kivun hoidon merkitys kuntoutumisessa : kivun kirjaaminen ja sairaanhoitajien kokemukset kipumittarin käytöstä

Tämän opinnäytetyön tarkoituksena oli selvittää kivun hoidon kirjaamista sekä sairaanhoitajien kokemuksia VAS-kipumittarin käytöstä Laakson sairaalan eräällä akuuttiosastolla. Opinnäytetyössä selvitettiin, mitä kivusta oli kirjattu potilaan päivittäisen hoitotyön seurannan lomakkeelle ennen VAS-kipumittarin käyttöä. Lisäksi osaston sairaanhoitajia haastateltiin heidän kokemuksistaan VAS-kipumittarin käytöstä. Tutkimusaineisto kerättiin Laakson sairaalassa kevään 2006 aikana. Tutkimukseen valittiin 21 potilaan päivittäisen hoitotyön seurannan lomakkeet, joita tarkasteltiin kivun kirjaamisen osalta. Potilasasiakirjoista selvitettiin mitä kivun ilmaisemisesta, määrittelystä, kivun hoidon suunnittelusta, toteutuksesta ja arvioinnista oli kirjattu. Tiedot kerättiin tutkimusta varten laaditulle strukturoidulle tiedonkeruulomakkeelle. Tulokset esitettiin lukuina kivun kirjaamisen määrästä edellä mainituilla osa-alueilla. Lisäksi neljää sairaanhoitajaa haastateltiin heidän kokemuksistaan VAS-kipumittarista, jota he olivat käyttäneet päivittäisessä hoitotyössä viikon ajan. Haastattelulomake koostui strukturoiduista kysymyksistä, jotka analysoitiin kvantitatiivisesti sekä avokysymyksistä. Tulokset esitettiin sanallisesti. Opinnäytetyön tuloksista kävi ilmi, että osaston tulisi kiinnittää kivun arvioimiseen sekä kivun kirjaamiseen enemmän huomiota. Kivun arvioinnin tulisi olla säännöllisempää. Erityisesti kivun hoidon vaikuttavuutta tulisi huomioida kirjaamisessa enemmän. Myös potilaan kivuttomuus tulisi kirjata. Sairaanhoitajien haastattelusta selvisi, että VAS-kipumittari oli hoitajalle helppokäyttöinen, mutta potilaan kannalta mittarin käytössä ilmeni hankaluuksia. VAS-kipumittari ei osoittautunut parhaaksi mahdolliseksi kivunarviointimenetelmäksi osaston potilaille. Tuloksista ilmeni, että VAS-kipumittaria ei käytetty säännöllisesti kivun arvioimisessa. Tärkeämpää kuin sopivimman kipumittarin valinta, olisikin yhden mittarin systemaattinen käyttö päivittäisessä hoitotyössä. Hoitajia tulisi myös kouluttaa kivun hoidosta ja merkityksestä kuntoutuvan potilaan hoitotyössä, jotta kipumittarin käyttö vastaisi tarkoitustaan.

Smoked cannabis and doping control: looking for the wrong target analyte?

Introduction: Since 2004, cannabis is prohibited by the World Anti-Doping Agency (WADA) for all sports in competition. In the years since then, about half of all positive doping cases in Switzerland have been related to cannabis consumption. In most cases, the athletes plausibly claim to have consumed cannabis several days or even weeks before competition and only for recreational purposes not related to competition. In doping analysis, the target analyte in urine samples is 11-nor-delta-9-tetrahydrocannabinol- 9-carboxylic acid (THC-COOH), the reporting threshold for laboratories is 15 ng/mL. However, the wide detection window of this long-term THC metabolite in urine does not allow a conclusion concerning the time of consumption or the impact on the physical performance. Aim: The purpose of the present pharmacokinetic study on volunteers was to evaluate target analytes with shorter urinary excretion time. Subsequently, urines from athletes tested positive for cannabis should be reanalyzed including these analytes. Methods: In an one-session clinical trial (approved by IRB, Swissmedic, and Federal Office of Public Health), 12 healthy, male volunteers (age 26 ± 3 yrs, BMI 24 ± 2 kg/m2) with cannabis experience (> once/month) smoked a Cannabis cigarette standardized to 70 mg THC/cigarette (Bedrobinol® 7%, Dutch Office for Medicinal Cannabis) following a paced-puffing procedure. Plasma and urine was collected up to 8 h and 11 days, respectively. Total THC, 11-hydroxy-THC (THC-OH), and THC-COOH were determined after enzymatic hydrolyzation followed by SPE and GC/MS-SIM. The limit of quantitation (LOQ) for all analytes was 0.1 ng/mL. Visual analog scales (VAS) and vital functions were used for monitoring psychological and somatic side-effects at every timepoint of specimen collection (up to 480 min). Results: Eight puffs delivered a mean THC dose of 45 mg. Mean plasma levels of total THC, THC-OH and THC-COOH were measured in the range of 0.1-20.9, 0.1-1.8, and 1.8-7.5 ng/mL, respectively. Peak concentrations were observed at 5, 10, and 90 min. Mean urine levels were measured in the range of 0.1-0.7, 0.10-6.2, and 0.1-13.4 ng/mL, respectively. The detection windows were 2-8, 2-96, and 2-120 h. No or only mild effects were observed, such as dry mouth, sedation, and tachycardia. Besides high to very high THC-COOH levels (0-978 ng/mL), THC (0.1-24 ng/mL) and THC-OH (1-234 ng/mL) were found in 90 and 96% of the cannabis-positive urines from athletes. Conclusion: Instead of or in addition to THC-COOH, the pharmacologically active THC and THC-OH should be the target analytes for doping urine analysis. This would allow the estimation of more recent Cannabis consumption, probably influencing performance during competition. Keywords: cannabis, doping, clinical trial, plasma and urine levels, athlete's samples

Do orthopaedic shoes improve local dynamic stability of gait? An observational study in patients with chronic foot and ankle injuries.

BACKGROUND: Complex foot and ankle fractures, such as calcaneum fractures or Lisfranc dislocations, are often associated with a poor outcome, especially in terms of gait capacity. Indeed, degenerative changes often lead to chronic pain and chronic functional limitations. Prescription footwear represents an important therapeutic tool during the rehabilitation process. Local Dynamic Stability (LDS) is the ability of locomotor system to maintain continuous walking by accommodating small perturbations that occur naturally during walking. Because it reflects the degree of control over the gait, LDS has been advocated as a relevant indicator for evaluating different conditions and pathologies. The aim of this study was to analyze changes in LDS induced by orthopaedic shoes in patients with persistent foot and ankle injuries. We hypothesised that footwear adaptation might help patients to improve gait control, which could lead to higher LDS: METHODS: Twenty-five middle-aged inpatients (5 females, 20 males) participated in the study. They were treated for chronic post-traumatic disabilities following ankle and/or foot fractures in a Swiss rehabilitation clinic. During their stay, included inpatients received orthopaedic shoes with custom-made orthoses (insoles). They performed two 30s walking trials with standard shoes and two 30s trials with orthopaedic shoes. A triaxial motion sensor recorded 3D accelerations at the lower back level. LDS was assessed by computing divergence exponents in the acceleration signals (maximal Lyapunov exponents). Pain was evaluated with Visual Analogue Scale (VAS). LDS and pain differences between the trials with standard shoes and the trials with orthopaedic shoes were assessed. RESULTS: Orthopaedic shoes significantly improved LDS in the three axes (medio-lateral: 10% relative change, paired t-test p < 0.001; vertical: 9%, p = 0.03; antero-posterior: 7%, p = 0.04). A significant decrease in pain level (VAS score -29%) was observed. CONCLUSIONS: Footwear adaptation led to pain relief and to improved foot & ankle proprioception. It is likely that that enhancement allows patients to better control foot placement. As a result, higher dynamic stability has been observed. LDS seems therefore a valuable index that could be used in early evaluation of footwear outcome in clinical settings.

Mudanças na Imigração

Os da dos es ta tís ti cos so bre o re cen te cres ci men to da imi gra ção, com a emer gên cia de no vos flu xos (Les te) e a in ten si fi ca ção dos tra di ci o na is (PALOP e, so bre tu do, Bra sil), são ana li sa dos ten do em con ta o fac to de Por tu gal ser hoje, no con tex to eu ro peu, um dos pa í ses com me nor pro por ção de es tran ge i ros na po pu la ção re si den te e, si mul ta ne a men te, com um ma i or es go ta men to das re ser vas do seu mer ca do de tra ba lho in ter no.

Efficacy and Safety of Canakinumab Vs Triamcinolone Acetonide in Patients with Gouty Arthritis Unable to Use Nonsteroidal Anti-Inflammatory Drugs and Colchicine, and On Stable Urate Lowering Therapy (ULT) or Unable to Use ULT

Background/Purpose: The primary treatment goals for gouty arthritis (GA) are rapid relief of pain and inflammation during acute attacks, and long-term hyperuricemia management. A post-hoc analysis of 2 pivotal trials was performed to assess efficacy and safety of canakinumab (CAN), a fully human monoclonal anti-IL-1_ antibody, vs triamcinolone acetonide (TA) in GA patients unable to use NSAIDs and colchicine, and who were on stable urate lowering therapy (ULT) or unable to use ULT. Methods: In these 12-week, randomized, multicenter, double-blind, double-dummy, active-controlled studies (_-RELIEVED and _-RELIEVED II), patients had to have frequent attacks (_3 attacks in previous year) meeting preliminary GA ACR 1977 criteria, and were unresponsive, intolerant, or contraindicated to NSAIDs and/or colchicine, and if on ULT, ULT was stable. Patients were randomized during an acute attack to single dose CAN 150 mg s.c. or TA 40 mg i.m. and were redosed "on demand" for each new attack. Patients completing the core studies were enrolled into blinded 12-week extension studies to further investigate on-demand use of CAN vs TA for new attacks. The subpopulation selected for this post-hoc analysis was (a) unable to use NSAIDs and colchicine due to contraindication, intolerance or lack of efficacy for these drugs, and (b) currently on ULT, or contraindication or previous failure of ULT, as determined by investigators. Subpopulation comprised 101 patients (51 CAN; 50 TA) out of 454 total. Results: Several co-morbidities, including hypertension (56%), obesity (56%), diabetes (18%), and ischemic heart disease (13%) were reported in 90% of this subpopulation. Pain intensity (VAS 100 mm scale) was comparable between CAN and TA treatment groups at baseline (least-square [LS] mean 74.6 and 74.4 mm, respectively). A significantly lower pain score was reported with CAN vs TA at 72 hours post dose (1st co-primary endpoint on baseline flare; LS mean, 23.5 vs 33.6 mm; difference _10.2 mm; 95% CI, _19.9, _0.4; P_0.0208 [1-sided]). CAN significantly reduced risk for their first new attacks by 61% vs TA (HR 0.39; 95% CI, 0.17-0.91, P_0.0151 [1-sided]) for the first 12 weeks (2nd co-primary endpoint), and by 61% vs TA (HR 0.39; 95% CI, 0.19-0.79, P_0.0047 [1-sided]) over 24 weeks. Serum urate levels increased for CAN vs TA with mean change from baseline reaching a maximum of _0.7 _ 2.0 vs _0.1 _ 1.8 mg/dL at 8 weeks, and _0.3 _ 2.0 vs _0.2 _ 1.4 mg/dL at end of study (all had GA attack at baseline). Adverse Events (AEs) were reported in 33 (66%) CAN and 24 (47.1%) TA patients. Infections and infestations were the most common AEs, reported in 10 (20%) and 5 (10%) patients treated with CAN and TA respectively. Incidence of SAEs was comparable between CAN (gastritis, gastroenteritis, chronic renal failure) and TA (aortic valve incompetence, cardiomyopathy, aortic stenosis, diarrohea, nausea, vomiting, bicuspid aortic valve) groups (2 [4.0%] vs 2 [3.9%]). Conclusion: CAN provided superior pain relief and reduced risk of new attack in highly-comorbid GA patients unable to use NSAIDs and colchicine, and who were currently on stable ULT or unable to use ULT. The safety profile in this post-hoc subpopulation was consistent with the overall _-RELIEVED and _-RELIEVED II population.

L'ús de la cançó per a potenciar el desenvolupament del llenguatge d'un nen autista

L’ús de la cançó per a potenciar el desenvolupament del llenguatge d’un nen autista és un projecte que pretén donar una visió de la música com a eina per al desenvolupament del llenguatge verbal i no verbal dels nens amb diagnòstic de TEA (Trastorn de l’Espectre Autista). Busca també fer una revisió bibliogràfica en aquest camp per conèixer i relacionar una mica més aquests móns sovint desconeguts. Finalment, presenta un programa d’intervenció adreçat específicament a quatre alumnes amb TEA, amb necessitats i objectius diferents, amb el pertinent seguiment, anàlisi de les dades recollides durant la intervenció, conclusions, i noves vies de treball que es podrien dur a terme.

Flora de Cabo Verde - Plantas Vasculares. 67. Apiaceae

Er-vas frequentemente com cau!es sukados, muito raramente arbustos ou pequenasá rvores. Caulese m regra ocos ou com medulab em desenvolvida. Folhas alternas,e m regra muito divididas, ocasionalmentes implese , muito raramente, peltadas. Flores em umbelas simples ou mais frequentemente compostasr,a ramentev erticiladaso u capitadas,e m regra bissexuadams asp or vezes unissexuadapso r redu@o. Tubo do cálice unido ao ovário; limbo de 5 dentes em regra minúsculos ou ausentes. Pétalas 5, valvadas, epigínicas, brancas ou, raramente, amareladase, sverdeadaso u rosadaso u, muito raramente, azuis. Estames 5, livres, alternando com as pétalas; anteras 2-loculares, deiscentesp or fendas longitudinais. Estiletes 2, em regra divergentes, muitas vezes parcialmente unidos e frequentcmente com estilopódio bem desenvolvido. Ovario ínfero, Zlocular, com 1 óvulo pêndulo em cada lóculo. Fruto seco, em regra dividindo-se na maturacão em 2 mericarpos ligados a um carpóforo central resultante dos feixes vasculares principais do fruto. Os carpelosa presentamfr equentementec ostasb em desenvolvidase as paredes são providas em regra de canais oleíferos característicos. 0 fruto pode ser lateral- ou dorsahnentec omprimidoe ter asasla terais bem desenvolvidas ou apresentar espinhos ou ganchos. Sementes providas de endosperma oleoso abundante e com embriões muito pequenos. Familia com cerca de 418 génerose 3100e speciese, ssencialmentcea racterística dasr egiõest emperadamentqe uentesd o Globo. Facilmenter econhecível pelo hábito geralmente herbáceo, a disposicão característica das flores em umbelas e principalmente pelo fruto em regra divisivel em 2 mericarpos

What kind of relationships between the evolution of pain, beliefs and bio-psycho-social complexity after a locomotor traumatism?

Introduction: Pain and beliefs have an influence on the patient's course in rehabilitation, pain causes fears and fears influence pain perception. The aim of this study is to understand pain and beliefs evolutions during rehabilitation taking into account of bio-psycho-social complexity.Patients and methods: 631 consecutive patients admitted in rehabilitation after a musculoskeletal traumatism were included and assessed at admission and at discharge. Pain was measured by VAS (Visual Analogical Scale), bio-psycho-social complexity by Intermed scale, and beliefs by judgement on Lickert scales. Four kinds of beliefs were evaluated: fear of a severe origin of pain, fear of movement, fear of pain and feeling of distress (loss of control). The association between the changes in pain and beliefs during the hospitalization was assessed by linear regressions.Results: After adjustment for gender, age, education and native language, patients with a decrease in pain during rehabilitation have higher probability of decreasing their fears. For the distress feeling, this relationship is weaker among bio-psycho-socially complex patients (odds-ratio 1.22 for each decreasing of 10mm/100 VAS) than among non-complex patients (OR 1.47). Patients with a pain decrease of 30% or more during hospitalization have higher probability of seeing their fears decrease, this relationship being stronger in complex patient for fear of a severe origin of pain.Discussion: The relationships between evolution of pain and beliefs move in the same direction. The higher a patient feels pain, the less they could be able to modify their dysfunctional beliefs. When the pain diminishes of 30% or more, the probability to challenge the beliefs is increased. The prognostic with regard to feeling of distress and fear of a severe origin of pain, is worse among bio-psycho-socially complex patients.

A prospective randomised double-blind controlled trial evaluating the effect of trans-sacral magnetic stimulation in women with overactive bladder.

Overactive bladder (OAB) is a prevalent condition with 16% of adults having one or more symptoms that significantly affect quality of life. Transcutaneous electrical nerve stimulation and neuromodulators have had success in treating OAB but are expensive, invasive, and sometimes cumbersome. We developed an alternative neuromodulatory technique that involves electromagnetic stimulation of the sacral nerve roots with a portable electromagnetic device to produce trans-sacral stimulation of the S3 and S4 sacral nerve roots. The aim of this study was to evaluate the impact of this device on OAB symptoms in women with a prospectively randomised double-blind controlled study. Following a power analysis, women with symptoms of OAB were prospectively recruited with ethical approval for randomisation to an active treatment (n = 33) or placebo group (n = 30) in a double-blind trial. The patient, at home, used the belt device daily for 20 min over 12 weeks. Outcome measures included a 3-day voiding diary, 1 h pad test, visual analogue score (VAS) for symptom impact (0-100%), Kings Health Questionnaire (KHQ) and Australian Quality of Life questionnaire (AQOL) at baseline, 6 and 12 weeks. Overall, no difference was found between groups for any of the research questions. Specifically, we were unable to demonstrate any difference between the active and sham device groups in frequency, nocturia, urinary leakage, or quality of life, nor was there any evidence of a placebo effect. The quality of the data was high with the number of missing observations (especially for disease specific KHQ and general AQOL) being few. This attempt to promote trans-sacral electromagnetic neuromodulation with a specially created device was ineffective on the symptoms of OAB.

Is it really worth the effort to renounce to 5 mm trocars?

Objective: Single port laparoscopy andNOTES aim at decreasing the number¦of trocars, at a price of increased technical difficulty and cost, without until now¦any proof of benefit for the patient.Morbidity related to 5 mm trocar sites (TS)¦is claimed to be low, but there are no good quality data on this topic. The aim¦of the present prospective study is to measure the morbidity and overall specific¦impact related to the 5 mm TS and compare them to larger TS.¦Methods:Wecollected prospectively data on 300 consecutive patients operated¦by laparoscopy in our institution between 2009 and 2010. Pain, morbidity,¦cosmetic, and overall patient discomfort were assessed specifically for each¦TS, using standardized questionnaires, at 3 time points: at discharge from¦the hospital, at 1 month and at 6 months after surgery. Results were compared¦between 5 mmand larger TS (10 mm, 12 mmand 15 mm).Trocar sites replaced¦by a minilaparotomy or a stoma were excluded from analysis. In this study we¦present the short-term results.¦Results: Three-hundred patients (mean age 47·5, women 55%) were operated¦with 1074 TS of which 477(44%) were 5 mm TS. Indication to laparoscopy was¦cholecystectomy (31·3%), appendectomy (26·6%), upper GI surgery (16·3%),¦colon resection (13·3%) or other (12·3%). Follow-up at 1 month was completed¦in 90%.¦The 5 mm TS had an infection rate of 0·2%, and a hematoma rate of 1·7%.¦VAS pain scores at the 5mm TS were ≤3 in 91·6% at rest and in 75·9% upon¦effort at discharge, and in 97% at 1 month. Median patient scar assessment¦score (PSAS) of the 5 mm TS at 1 month was 6 (IQR: 2-9) out of 60 (0 =¦best score). Overall discomfort of the 5 mm TS in a VAS scale was 0 in 77%¦and ≤3 in 95% of patients at 1 month. Morbidity, pain assessments, PSAS, and¦overall discomfort scores were all significantly better for 5 mm TS compared to¦larger TS.¦Conclusion: Morbidity, pain, cosmetic impact and overall patient's discomfort¦related to a 5 mm trocar site is extremely low. For this reason, any potential¦advantage related to omitting 5 mm trocars to perform the same type of surgery¦will be difficult to demonstrate.

Asociaciones de peces demersales en el norte del mar peruano durante el verano 2001

Analiza las asociaciones de peces demersales frente a la costa norte del Perú mediante las técnicas estadísticas multivariadas de clasificación de dos vías y de ordenamiento.

Efectos del tamaño de anzuelo sobre capturas y tallas del perico Coryphaena hippurus

Se evidenció alta selección interespecífica del espinel superficial experimental, al capturar 130 ejemplares de perico Coryphaena hippurus (87,8%) del total de 148 especímenes que incluyeron 8 especies entre peces, tortugas y cefalópodos; como pesca incidental se registró 1 enganche por lance de tortugas (verde Chelonia mydas y amarilla Caretta caretta). El anzuelo más eficiente para la captura de esta especie, fue el de menor calibre (Nº 6) que capturó 24,6%, el menos eficiente fue el Nº 5 (16,9%); sin embargo, mediante el ANOVA de dos vías se estableció que no existía efecto del tamaño de anzuelo sobre el número de ejemplares capturados (p= 0,963). Los anzuelos no evidenciaron una selección de tallas, al no establecerse diferencias significativas entre distribución de tallas (p= 0,538), excepto para los anzuelos Nº 2 y 6 (p= 0,084), al identificarse diferencia por efecto del tamaño de anzuelo. Las longitudes medias estimadas fueron 119,7 cm, 116,8 cm, 118,3 cm, 115,0 cm y 113,7 cm, para los anzuelos Nº 2, 3, 4, 5 y 6, respectivamente. El tamaño de anzuelo mostró un fuerte efecto sobre el tipo de enganche (p= 0,002), presentándose con mayor frecuencia los enganches en la agalla (53,1%) y boca (44,6%). Generalmente los enganches en la agalla son ocasionados por los anzuelos grandes (Nº 2 y 3), mientras que los de boca son realizados por los anzuelos más pequeños (Nº 5 y 6). La captura por unidad de esfuerzo (CPUE) global del longline experimental fue 1,2 ejemplares de perico para un esfuerzo de 1000 anzuelos por hora, lo que representa la tercera parte de la CPUE estimada para la flota comercial.

Equipamento para extração de amostras indeformadas de solo

O presente trabalho teve como objetivo desenvolver um equipamento para coletar amostras indeformadas de solo de 75 mm de diâmetro a uma profundidade de até 0,60 m, bem como avaliar a qualidade das amostras retiradas. O amostrador foi constituído por um tubo de PVC, acondicionado dentro de um tubo cravador de alumínio equipado com uma ponteira de aço, formando um conjunto sem movimento rotativo. Envolveu este conjunto uma rosca-sem-fim, equipada com três lâminas de corte na sua extremidade. O conjunto foi adaptado a um veículo especificamente projetado para o tráfego no campo (VAS - Veículo Amostrador de Solo). As amostras obtidas pelo VAS foram comparadas com as testemunhas, obtidas pelo método do bloco da parafina, por meio de testes laboratoriais, para verificar a ocorrência de alterações estruturais. Os testes foram: inspeção visual, densidade do solo, ensaio de compressão triaxial rápido e ensaio de adensamento. As amostras obtidas pelo VAS em solo argiloso (Latossolo Roxo) apresentaram confiabiliade (95%) dos valores de densidade do solo, características de resistência à compressão e adensamento iguais à testemunha. O equipamento mostrou-se prático, versátil e adequado para retirar amostras de solos argilosos, sendo a qualidade das amostras semelhante à obtida pelos métodos tradicionais de extração do anel volumétrico e de bloco de solos. O equipamento desenvolvido pode ser útil na coleta de dados para mapeamento de solos, com o auxílio de uma antena de GPS.